Overview
Azithromycin is a prominent member of the macrolide class of antibiotics, distinguished by its broad spectrum of activity and unique pharmacokinetic profile. It is highly valued in clinical practice due to its ability to achieve high concentrations in tissues and its exceptionally long half-life. This allows for convenient, short-course dosing regimens (often just 3 to 5 days) while providing sustained therapeutic effects. It is a first-line treatment for various infections, including community-acquired pneumonia, acute exacerbations of chronic bronchitis, sinusitis, pharyngitis/tonsillitis, uncomplicated skin infections, and sexually transmitted infections like chlamydia.

Mechanism of Action
Azithromycin exerts its bacteriostatic (and sometimes bactericidal, depending on concentration and susceptibility) effect by binding to the 50S ribosomal subunit of susceptible microorganisms. This binding specifically interferes with microbial protein synthesis by preventing the translocation of peptides. Without the ability to synthesize essential proteins, the bacteria cannot grow or multiply, allowing the body’s immune system to clear the infection.

Dosage and Administration
The dosage regimen for azithromycin is highly specific to the indication. For typical respiratory or skin infections in adults, a common regimen is 500 mg on day 1, followed by 250 mg once daily on days 2 through 5. For chlamydia trachomatis infections, a single 1-gram dose is often sufficient. Pediatric dosing is based on weight, commonly 10 mg/kg on day 1, followed by 5 mg/kg on days 2-5. Most formulations can be taken with or without food, but taking it with food may reduce gastrointestinal side effects.

Side Effects and Risks
Azithromycin is generally well-tolerated, with the most frequent side effects being mild gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. However, it carries a significant warning regarding the potential for QT interval prolongation, which can lead to severe and potentially fatal cardiac arrhythmias, including torsades de pointes. This risk is particularly elevated in patients with known prolonged QT intervals, hypokalemia, hypomagnesemia, or those taking other QT-prolonging drugs.

Contraindications
It is contraindicated in patients with a known hypersensitivity to azithromycin, erythromycin, or any other macrolide or ketolide antibiotic. It should also be avoided in patients with a history of cholestatic jaundice or hepatic dysfunction associated with prior use of azithromycin. Extreme caution is required when prescribing to patients with severe hepatic impairment or significant cardiac disease.

Pregnancy and Lactation
Azithromycin is generally considered safe for use during pregnancy when clearly needed. Animal reproduction studies have not demonstrated evidence of harm to the fetus. It is excreted in human breast milk, and while generally considered compatible with breastfeeding, the infant should be monitored for potential side effects such as diarrhea or candidiasis.